360 Stem Cell & Regenerative Medicine Newsletter - August 5, 2014

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - August 5, 2014

Featured video from Mayo Clinic: Mayo Clinic: Jorge and Leslie Bacardi-paying forward the gift of life
Paying Forward the Gift of Life: Jorge and Leslie Bacardi
Regenerative medicine is no longer science fiction, and a leadership level gift from Jorge and Leslie Bacardi of the Bahamas will accelerate the research of Mayo Clinic's Center for Regenerative Medicine on the Florida campus.
WSJ- LATE BREAKING NEWS: Japanese stem-cell scientist Yoshiki Sasai is dead. Co-Author of STAP studies on stem cells found dead after apparent suicide.
Editor’s comment: The entire stem cell universe is shaken by this tragic news and we collectively mourn the loss. We extend to Dr. Sasai’s family and to the RIKEN community our deepest sympathies. By all accounts, Dr. Sasai was a dedicated researcher and still had much to contribute. It is imperative that RIKEN move forward with its ongoing research for the betterment of human health and the alleviation of human suffering.
Discover Magazine: New hope for soldiers disfigured in war
This lengthy article is amazing- a tour de force, telling the story of Col. Robert Hale at the U.S. Army Institute of Surgical Research in San Antonio and his quest to treat Sgt. Todd Nelson, who suffered devastating facial trauma on the battlefield. A host of innovative regenerative medicine treatments were employed to rebuild the wounded warrior’s face. The article also describes the many contributions of the Armed Forces Institute of Regenerative Medicine (AFIRM) that has poured $265 million to focus on salvaging limbs, preventing surgical complications, enable body healing, restoring skin after burns and healing faces.
Sacramento Bee: Speaking out about living in silence with incurable Huntington disease
Mona Grable lost her brother Jim to Huntington’s disease, an affliction she refers to as ”incurable and dreadful.” In this thoughtful piece, she describes Jim’s torment and the importance of public awareness. She recently attended the conference organized by the grassroots group Help4HD International. There she met dedicated scientists, including Dr. Jan Nolta who leads the UC Davis Stem Cell Program. Let’s join Mona and other advocates in their cause to support research and clinical trials aimed at finding a cure for Huntington’s disease, sooner rather than later.
CRG researchers confirm that a mathematical theory first proposed by Alan Turing in 1952 can explain the formation of fingers
In a paper published in Science, researchers from the Centre for Genomic Regulation (CRG) in Barcelona have shown that BMP and WNT proteins are the so-called “Turing molecules” for creating embryonic fingers. The CRG press release states that, "Arriving at the correct understanding of multicellular organization is essential if we are to develop effective strategies for regenerative medicine, and one day to possibly engineer replacement tissues for various organs."
Sports Illustrated: Stem cell treatment: out from the shadows, onto the cutting edge
Jenny Vrentes in Sports Illustrated blows the lid on NFL players relying on stem cell treatments to keep them in the game. “The Jets’ Chris Johnson is one of hundreds of NFL players who’ve turned to stem cells to aid in recovery from injury. It may be the next big breakthrough in the treatment of sports ailments, but for now the use of such therapy is strictly limited in the U.S.—and questions about effectiveness outweigh the answers.”
The New York Stem Cell Foundation partners with Beyond Batten Disease Foundation to fight Juvenile Batten Disease
Two wonderful organizations, the New York Stem Cell Foundation (NYSCF) and Beyond Batten Disease Foundation (BBDF) have partnered to develop stem cell resources to investigate and explore new treatments and ultimately find a cure for juvenile Batten disease, a fatal illness affecting children.
NYSCF scientists one step closer to cell therapy for Multiple Sclerosis patients
“Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells. For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.”
San Antonio-based Targazyme, Inc. awarded SBIR grant from National Eye Institute
Targazyme, Inc. a clinical-stage biopharmaceutical company developing enzyme technologies and products to improve efficacy outcomes for cancer immunotherapy and cell therapy, received an SBIR award to fund its program for a novel cell-based restorative approach to treat diabetes-related retinopathy. This SBIR award is from the National Eye Institute and Targazyme will be collaborating with researchers from the Department of Ophthalmology at Indiana University School of Medicine to conduct the research.

360 Newsletter Editor

Bernard Siegel
Executive Director
Genetics Policy Institute

Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter

About GPI

The nonprofit Genetics Policy Institute (GPI) seeks to establish a positive policy, regulatory and societal framework to enable research to flourish, under the highest ethical and medical standards. We seek to accelerate the discovery and development of lifesaving cures and therapies to alleviate human suffering due to chronic and terminal afflictions. Visit Website.

ConnectGPI on FacebookGPI on TwitterGPI on LinkedIn

Bringing our World Together- the World Stem Cell Summit
Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018